25,400 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Exome Asset Management LLC

Key Points

• Exome Asset Management LLC acquired 25,400 shares of GE HealthCare Technologies valued at approximately $2,050,000, making it the firm's 27th largest holding.
• The company reported earnings of $1.06 per share for the last quarter, exceeding analysts' expectations, with revenue increasing to $5 billion, a 3.5% year-over-year growth.
• GE HealthCare Technologies has a consensus target price of $88.40, with multiple analysts giving it "buy" and "strong buy" ratings amid recent positive research reports.

Exome Asset Management LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 25,400 shares of the company's stock, valued at approximately $2,050,000. GE HealthCare Technologies makes up about 1.7% of Exome Asset Management LLC's investment portfolio, making the stock its 27th biggest position.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Empowered Funds LLC grew its holdings in shares of GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company's stock worth $2,328,000 after purchasing an additional 1,665 shares in the last quarter. HFM Investment Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the first quarter worth about $60,000. MBB Public Markets I LLC purchased a new position in shares of GE HealthCare Technologies during the first quarter worth about $328,000. Meiji Yasuda Asset Management Co Ltd. grew its holdings in shares of GE HealthCare Technologies by 6.7% during the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 6,862 shares of the company's stock worth $554,000 after purchasing an additional 429 shares in the last quarter. Finally, Sciencast Management LP purchased a new position in shares of GE HealthCare Technologies during the first quarter worth about $3,522,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently commented on GEHC shares. Morgan Stanley cut their price objective on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Citigroup upped their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. BTIG Research reaffirmed a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Finally, Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $88.40.

GE HealthCare Technologies Trading Up 2.6%

Shares of NASDAQ:GEHC traded up $1.97 during trading on Thursday, reaching $77.96. 4,355,639 shares of the company traded hands, compared to its average volume of 2,891,212. The firm has a market capitalization of $35.59 billion, a price-to-earnings ratio of 15.98, a P/E/G ratio of 2.90 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The business's fifty day moving average is $74.45 and its 200-day moving average is $73.76.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business's quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.